Cargando…

Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis

SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) are major infectious causes of death, with meta-analyses and population-based studies finding increased mortality in co-infected patients simultaneously diagnosed with COVID-19 and tuberculosis (TB). There is a need to understand the immune interaction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Booysen, Petro, Wilkinson, Katalin A., Sheerin, Dylan, Waters, Robyn, Coussens, Anna K., Wilkinson, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569495/ https://www.ncbi.nlm.nih.gov/pubmed/37841282 http://dx.doi.org/10.3389/fimmu.2023.1254206

Ejemplares similares

Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection
por: Shah, Taif, et al.
Publicado: (2022)

Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
por: Shaw, Jane Alexandra, et al.
Publicado: (2023)

The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?
por: Seddon, James A., et al.
Publicado: (2018)

Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood
por: Lowe, David M., et al.
Publicado: (2018)

Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences
por: Aiello, Alessandra, et al.
Publicado: (2023)

The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
por: Coppola, Mariateresa, et al.
Publicado: (2021)

Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons
por: Wilkinson, Katalin A., et al.
Publicado: (2021)

The Mtb-HIV syndemic interaction: why treating M. tuberculosis infection may be crucial for HIV-1 eradication
por: Waters, Robyn, et al.
Publicado: (2020)

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
por: Baker, Paul J., et al.
Publicado: (2023)

The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis
por: Jhilmeet, Nishtha, et al.
Publicado: (2018)

Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis
por: Mzinza, David T., et al.
Publicado: (2015)

Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes
por: Rockwood, Neesha, et al.
Publicado: (2017)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis
por: Shey, Muki Shehu, et al.
Publicado: (2023)

Adaptive Immune Responses and Immunity to SARS-CoV-2
por: Primorac, Dragan, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
por: Liang, Yanwen, et al.
Publicado: (2020)

Immunity to SARS-CoV-2: Lessons Learned
por: Fergie, Jaime, et al.
Publicado: (2021)

SARS-CoV-2 and the host-immune response
por: Maison, David P., et al.
Publicado: (2023)

Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D₃
por: Coussens, Anna K., et al.
Publicado: (2015)

Analysis of the Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells to Discriminate Latent from Active Tuberculosis in HIV-Uninfected and HIV-Infected Individuals
por: Riou, Catherine, et al.
Publicado: (2017)

Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues
por: Subbarayan, Karthikeyan, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Early innate cell interactions with Mycobacterium tuberculosis in protection and pathology of tuberculosis
por: Sankar, Poornima, et al.
Publicado: (2023)

Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
por: Cao, Yingying, et al.
Publicado: (2021)

PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
por: Day, Cheryl L., et al.
Publicado: (2018)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Immunity to the Dual Threat of Silica Exposure and Mycobacterium tuberculosis
por: Konečný, Petr, et al.
Publicado: (2019)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
por: Petruccioli, Elisa, et al.
Publicado: (2021)

When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
por: Taoufik, Yassine, et al.
Publicado: (2021)

Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria
por: Eggenhuizen, Peter J., et al.
Publicado: (2022)

Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents
por: Tsang, Hing Wai, et al.
Publicado: (2021)

Immune modulation as a consequence of SARS-CoV-2 infection
por: Gelmez, Metin Yusuf, et al.
Publicado: (2022)

Cellular immune states in SARS-CoV-2-induced disease
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Complementarity determining regions in SARS-CoV-2 hybrid immunity
por: Frans, Glynis, et al.
Publicado: (2023)

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
por: Shen, Jiaying, et al.
Publicado: (2023)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review
por: Bostanghadiri, Narjess, et al.
Publicado: (2022)

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
por: Mooij, Petra, et al.
Publicado: (2022)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_18dhvvun1itvpl3ddf60q6flo0